Kioson Komersial Indonesia Tbk vs Merck Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp92 (market cap 100.06B, 38.92M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 17× Kioson Komersial Indonesia Tbk's market cap, and Kioson Komersial Indonesia Tbk is more actively traded (38.92M versus 37.6K). Which is the better fit depends on your goals.
| KIOS | MERK | |
|---|---|---|
Market Cap | 100.06B | 1.7T |
Volume | 38.92M | 37.6K |
Lot | 389.22K | 376 |
Turnover | 3.62B | 144.47M |
Average Price | 93.12 | 3,842.23 |
Value | 3.62B | 144.47M |
Indicative Equilibrium Price | 92 | 3,840 |
Indicative Equilibrium Volume | 1.83K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.
Read more on KIOS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →